IDEAYA Biosciences, Inc. IDYA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

58/100

4/7 Pass

SharesGrow Intrinsic Value

IDEAYA Biosciences, Inc. (IDYA) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Hata Yujiro S avec 600,000 actions. Parmi les autres détenteurs notables BVF PARTNERS L P/IL et WHITE MICHAEL ANTHONY.

Au cours des 12 derniers mois, les initiés ont effectué 19 transactions sur IDYA l'action — 18 achats (d'une valeur de $52.62M) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.

IDYA Participations des Initiés

Principal Actionnaire

Hata Yujiro S

600,000 actions

Achats (12 mois)

$52.62M valeur

Ventes (12 mois)

$0.00 valeur

Activité de transactions (12 mois)

Acheter 95%

Vendre 0%

Principaux actionnaires initiés

#	Nom	Rôle	Actions détenues	Dernière déclaration	Taille relative
1	Hata Yujiro S	President and CEO	600,000	2026-02-02	100%
2	Bvf Partners L P/il	Officer	233,150	2021-02-04	39%
3	White Michael Anthony	Chief Scientific Officer	190,000	2026-02-02	32%
4	Beaupre Darrin	Chief Medical Officer	175,000	2026-02-02	29%
5	Bleharski Joshua	Chief Financial Officer	170,000	2026-02-02	28%
6	Dorman Stuart	Chief Commercial Officer	155,000	2026-02-02	26%
7	5am Ventures Iv, L.p.	10 Percent Owner	91,142	2020-11-13	15%
8	Hambleton Julie	SVP, Chief Medical Officer	62,500	2020-02-25	10%
9	Stein Jeffrey	Director	54,281	2026-03-02	9%
10	Lackner Mark	SVP, Head of Biology	45,000	2021-02-26	8%
11	Ruiz Briseno Andres	See Remarks	25,213	2026-02-02	4%
12	Dillon Michael P.	SVP, Chief Scientific Officer	23,437	2021-10-07	4%
13	Mackey Catherine J	Director	20,000	2025-06-26	3%
14	Rosen Terry J	Director	20,000	2025-06-26	3%
15	Yarno Wendy L	Director	20,000	2025-06-26	3%
16	Hampton Malcolm Garret	Director	20,000	2025-06-26	3%
17	Morrison Scott W	Director	20,000	2025-06-26	3%
18	Shannon Timothy M	Director	16,200	2023-06-09	3%
19	Kelley Susan L.	Director	16,200	2024-05-31	3%
20	Diekman John D	Director	11,000	2019-12-19	2%

Transactions récentes (12 derniers mois)

Date	Nom	Rôle	Type	Actions	Prix	Valeur
2026-03-02	Stein Jeffrey	Director	Achat Informatif	50,000	$32.96	$1.65M
2026-01-30	Bleharski Joshua	Chief Financial Officer	Attribution de RSU	170,000	$32.19	$5.47M
2026-01-30	Dorman Stuart	Chief Commercial Officer	Attribution de RSU	155,000	$32.19	$4.99M
2026-01-30	Ruiz Briseno Andres	See Remarks	Attribution de RSU	80,000	$32.19	$2.58M
2025-11-28	Ruiz Briseno Andres	See Remarks	Attribution de RSU	1,253	$16.91	$21.18K
2024-11-29	Ruiz Briseno Andres	See Remarks	Attribution de RSU	682	$23.26	$15.86K
2026-01-30	White Michael Anthony	Chief Scientific Officer	Attribution de RSU	190,000	$32.19	$6.12M
2026-01-30	Snyder Douglas B.	SVP, General Counsel	Attribution de RSU	130,000	$32.19	$4.18M
2025-11-28	Snyder Douglas B.	SVP, General Counsel	Attribution de RSU	1,041	$16.91	$17.6K
2025-05-30	Snyder Douglas B.	SVP, General Counsel	Attribution de RSU	1,039	$16.91	$17.57K
2026-01-30	Hata Yujiro S	President and CEO	Attribution de RSU	600,000	$32.19	$19.31M
2026-01-30	Beaupre Darrin	Chief Medical Officer	Attribution de RSU	175,000	$32.19	$5.63M
2025-06-27	Bleharski Joshua	Chief Financial Officer	Inconnu	250,000	$20.05	$5.01M
2025-06-24	Hampton Malcolm Garret	Director	Attribution de RSU	20,000	$21.78	$435.6K
2025-06-24	Morrison Scott W	Director	Attribution de RSU	20,000	$21.78	$435.6K
2025-06-24	Mackey Catherine J	Director	Attribution de RSU	20,000	$21.78	$435.6K
2025-06-24	Stein Jeffrey	Director	Attribution de RSU	20,000	$21.78	$435.6K
2025-06-24	Rosen Terry J	Director	Attribution de RSU	20,000	$21.78	$435.6K
2025-06-24	Yarno Wendy L	Director	Attribution de RSU	20,000	$21.78	$435.6K